Physician profile
Bao D Dao
NPI 1033349485
$33,713.78
in general payments reported to CMS, 2019-2025
100 companies · $6,114 in 2025
The $6,114 reported for 2025 was more than what 84% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,363 · 2020: $3,128 · 2021: $4,143 · 2022: $4,540 · 2023: $5,451 · 2024: $5,974 · 2025: $6,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Education: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,401.05 |
| Education | $138.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $3,212.32 | 2019-2025 | Erleada, Darzalex, Rybrevant |
| Astrazeneca Pharmaceuticals LP | $1,997.74 | 2019-2025 | Enhertu, Imfinzi, Tagrisso |
| Novartis Pharmaceuticals Corporation | $1,941.56 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $1,780.44 | 2019-2025 | Ninlaro, Iclusig, Fruzaqla |
| Pfizer INC. | $1,615.06 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,574.37 | 2019-2025 | Keytruda, Lynparza, Welireg |
| E.R. Squibb & Sons, L.L.C. | $1,482.83 | 2019-2025 | Opdivo |
| Celgene Corporation | $1,274.27 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Astellas Pharma US INC | $1,122.89 | 2019-2025 | Xospata, Vyloy, Padcev |
| Amgen INC. | $1,072.80 | 2019-2025 | Evenity, Prolia, Xgeva |
| Eisai INC. | $980.19 | 2019-2025 | |
| Lilly USA, LLC | $823.66 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Seagen INC. | $743.65 | 2020-2023 | Padcev, Tukysa, Adcetris |
| Genzyme Corporation | $650.06 | 2019-2025 | |
| Genentech USA, INC. | $607.20 | 2019-2025 | Polivy, Lunsumio, Venclexta |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | $606.64 | 2019-2023 | Imbruvica, Epkinly |
| Daiichi Sankyo INC. | $545.67 | 2019-2025 | Enhertu, Datroway, Injectafer |
| Coherus Oncology, INC. | $506.26 | 2020-2025 | Loqtorzi |
| Incyte Corporation | $497.70 | 2020-2025 | Monjuvi, Jakafi, Niktimvo |
| Kite Pharma, INC. | $485.49 | 2019-2024 | Yescarta |
| Array Biopharma INC | $461.87 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Jazz Pharmaceuticals INC. | $460.09 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $396.42 | 2019-2025 | Gilotrif, Jardiance |
| Organon LLC | $393.02 | 2021-2025 | Ontruzant |
| Stemline Therapeutics INC. | $384.95 | 2023-2025 | Orserdu, Elzonris |
| Glaxosmithkline, LLC. | $371.32 | 2020-2025 | Zejula, Jemperli, Ojjaara |
| Bayer Healthcare Pharmaceuticals INC. | $354.93 | 2019-2025 | |
| Abbvie INC. | $319.90 | 2024-2025 | |
| Adc Therapeutics America, INC. | $305.80 | 2021-2025 | |
| Gilead Sciences, INC. | $300.21 | 2019-2025 | Trodelvy |
| Regeneron Healthcare Solutions, INC. | $292.22 | 2020-2025 | Libtayo |
| Rigel Pharmaceuticals, INC. | $244.63 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Sobi, INC | $242.49 | 2022-2025 | |
| Octapharma USA, INC. | $232.15 | 2023-2025 | Panzyga, Octagam Immune Globulin (Human) |
| Ipsen Biopharmaceuticals, INC | $224.89 | 2020-2024 | Somatuline Depot, Onivyde |
| Aurobindo Pharma USA, INC. | $216.10 | 2019-2020 | |
| Beigene USA, INC. | $215.44 | 2020-2025 | Brukinsa |
| Puma Biotechnology, INC. | $200.94 | 2020-2024 | |
| Pharmacosmos Therapeutics INC. | $200.17 | 2023-2025 | Monoferric |
| Alexion Pharmaceuticals, INC. | $197.32 | 2019-2025 | Ultomiris |
| Emd Serono, INC. | $190.75 | 2021-2025 | Bavencio, Tepmetko |
| Aveo Pharmaceuticals, INC. | $165.05 | 2022-2025 | Fotivda |
| Taiho Oncology, INC. | $162.91 | 2020-2024 | |
| Myovant Sciences INC. | $161.07 | 2021-2022 | |
| Exelixis INC. | $156.00 | 2019-2025 | Cabometyx |
| Geron Corporation | $152.85 | 2024-2025 | Rytelo |
| Acrotech Biopharma INC. | $149.87 | 2021-2023 | Beleodaq |
| Lexicon Pharmaceuticals, INC. | $148.64 | 2019 | |
| Pharmaessentia USA Corporation | $141.20 | 2022-2025 | Besremi |
| Kyowa Kirin, INC. | $137.88 | 2021-2025 | Poteligeo |
| Tersera Therapeutics LLC | $136.77 | 2021-2025 | Zoladex, Xermelo |
| Servier Pharmaceuticals LLC | $127.39 | 2021-2025 | |
| Springworks Therapeutics, INC. | $114.09 | 2024-2025 | Ogsiveo |
| Sumitomo Pharma America, INC. | $102.30 | 2023-2024 | Orgovyx |
| Intuitive Surgical, INC. | $96.56 | 2021 | |
| Clovis Oncology, INC. | $86.64 | 2019-2022 | |
| Tactile Systems Technology INC | $86.22 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Foundation Medicine, INC. | $84.90 | 2019-2023 | |
| Agios Pharmaceuticals, INC. | $84.63 | 2024-2025 | Pyrukynd |
| Blueprint Medicines Corporation | $83.11 | 2021-2023 | Ayvakit |
| Beone Medicines USA, INC. | $83.04 | 2025 | Brukinsa |
| Legend Biotech USA INC. | $77.37 | 2025 | Carvykti |
| Dendreon Pharmaceuticals LLC | $76.24 | 2022-2024 | Provenge |
| Spectrum Pharmaceuticals INC. | $75.54 | 2025 | Rolvedon |
| Karyopharm Therapeutics INC. | $66.49 | 2020-2025 | Xpovio |
| Syndax Pharmaceuticals, INC. | $61.44 | 2025 | |
| Epizyme, INC. | $61.28 | 2020-2021 | |
| Global Blood Therapeutics, INC. | $60.51 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $54.81 | 2024-2025 | Alymsys, Neulasta, Neupogen |
| Tesaro, INC. | $53.05 | 2019 | |
| Caris Mpi, INC. | $50.77 | 2025 | Mi Cancer Seek |
| Iovance Biotherapeutics, INC. | $50.24 | 2025 | Amtagvi |
| Mirati Therapeutics, INC. | $49.89 | 2023 | Krazati |
| Cti Biopharma Corp. | $49.11 | 2023 | Vonjo |
| Fresenius Kabi USA, LLC | $46.52 | 2025 | Stimufend |
| Sun Pharmaceutical Industries INC. | $46.03 | 2024 | |
| Fennec Pharmaceuticals, INC. | $44.78 | 2024-2025 | Fyarro, Pedmark |
| Janssen Pharmaceuticals, INC | $44.69 | 2020-2021 | |
| Verity Pharmaceuticals INC. | $42.26 | 2024-2025 | Trelstar |
| Morphosys, US INC. | $41.92 | 2022-2023 | Monjuvi |
| Accord Healthcare, INC. | $41.89 | 2023-2025 | |
| Tempus Ai, INC | $40.61 | 2025 | Xt Cdx |
| Azurity Pharmaceuticals, INC. | $38.08 | 2024-2025 | Vivimusta, Danziten |
| Verastem, INC. | $37.81 | 2019 | |
| Amag Pharmaceuticals, INC. | $37.24 | 2021 | |
| Biocon Biologics INC | $34.23 | 2025 | Ogivri |
| Genmab U.S., INC. | $28.31 | 2025 | Epkinly |
| Apellis Pharmaceuticals, INC. | $24.54 | 2024 | Empaveli |
| Radius Health, INC. | $22.76 | 2025 | |
| Ferring Pharmaceuticals INC. | $22.55 | 2019 | |
| Dova Pharmaceuticals | $20.76 | 2021 | |
| Novocure INC. | $16.73 | 2025 | Optune Lua (Novottf-200t) |
| Novo Nordisk INC | $16.37 | 2021 | |
| Sandoz INC. | $16.20 | 2020 | |
| Advanced Accelerator Applications | $14.52 | 2019 | |
| Heron Therapeutics, INC. | $13.30 | 2022 | |
| Eusa Pharma (US) LLC | $13.00 | 2019 | |
| Grifols USA, LLC | $12.34 | 2021 | |
| Davol INC. | $11.91 | 2020 | |
| Mckesson Specialty Care Distribution, LLC | $10.16 | 2019 |
Drugs and devices associated with these payments
Keytruda $883Opdivo $704Lenvima $593Reblozyl $546Enhertu $545Ninlaro $489Imbruvica $472Kisqali $471Tukysa $413Orserdu $356Iclusig $343Lynparza $342Braftovi $333Mektovi $313Epkinly $312Imfinzi $304Tagrisso $296Erleada $294Darzalex $287Xtandi $285Udenyca $264Padcev $241Ibrance $235Zepzelca $230Lorbrena $227Rybrevant $219Libtayo $213Elrexfio $209Brukinsa $208Monoferric $200Ontruzant $194Monjuvi $179Akeega $173Verzenio $171Scemblix $170Rezlidhia $167Tavalisse $167Zejula $163Jemperli $163Orgovyx $160Fruzaqla $159Rytelo $153Panzyga $152Adcetris $150Jaypirca $149Tecvayli $140Fotivda $139Pluvicto $135Calquence $135Polivy $128Balversa $128Loqtorzi $128Xospata $127Talzenna $126Xalkori $120Gilotrif $117Ogsiveo $114Ojjaara $112Venclexta $111Besremi $111Mekinist $110Carvykti $108Vonjo $105Vyloy $103Ultomiris $101Jakafi $99.33Sarclisa $99.32Piqray $97.59Lunsumio $95.51Evenity $95.47Pomalyst $94.51Inqovi $94.51Lonsurf $94.51Ayvakit $93.19Inlyta $92.91Oxbryta $91.66Welireg $88.95Nubeqa $88.39Trodelvy $85.80Octagam Immune Globulin (Human) $80.61Prolia $78.56Cabometyx $76.53Rolvedon $75.54Poteligeo $75.39Vitrakvi $70.77Stivarga $70.77Xgeva $69.54Nplate $69.54Fabhalta $69.29Tasigna $68.93Ziihera $68.18Tecentriq $64.47Lutathera $62.99Jevtana $62.42Enjaymo $56.39Elitek $56.18Pyrukynd $55.23Xpovio $54.04Opdualag $53.77Bosulif $53.69
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bao Dao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.